In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A

Objective: Hemophilia A is an X-linked recessive bleeding disorder caused by a deficiency of plasma coagulation factor VIII (FVIII), and it accounts for about 80%-85% of all cases of hemophilia. Plasma-derived therapies or recombinant FVIII concentrates are used to prevent and treat the bleeding sym...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Cansu Hemşinlioğlu, Elif Sibel Aslan, Cihan Tastan, Didem Çakırsoy, Raife Dilek Turan, Utku Seyis, Muhammer Elek, Gözde Sır Karakuş, Ömür Selin Günaydın, Selen Abanuz, Derya Dilek Kançağı, Bulut Yurtsever, Koray Yalçın, Murat Kasap, Ercüment Ovalı
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Turkish Society of Hematology 2023-06-01
Ráidu:	Turkish Journal of Hematology
Fáttát:	factor viii gene therapy hemophilia a lentivirus mesenchymal stem cells
Liŋkkat:	https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-53911&look4=
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!